Alembic Pharma appoints Jigr Shah as Head - Business Finance
Vadodara: Alembic Pharma has announced the appointment of Jigr Shah as Head - Business Finance (Senior Management Personnel) of the Company.
"We would like to inform that Mr. Jigr Shah is appointed as Head - Business Finance (Senior Management Personnel) of the Company w.e.f. 15th May, 2025," Alembic pharma stated in a BSE filing.
Jigr Shah comes with 20+ years of business finance experience across India and emerging markets. His previous role at Dr.Reddy’s Laboratories (Vietnam) involved financial strategy, ABAC/SOX compliances and evaluating strategic growth initiatives to enhance regional capabilities across processes, systems and infrastructure. His prior experience includes roles at Mega Lifesciences (Vietnam), ITC, Ernst & Young and internship at Deloitte.
Read also: USFDA clears Alembic Pharma cardio drug Rivaroxaban, launch expected in next year
Headquartered in India, Alembic Pharmaceuticals Limited is a vertically integrated research and development pharmaceutical company. The company manufactures and markets generic pharmaceutical products all over the world. Alembic's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the USFDA.
Read also: Alembic Pharma bags USFDA nod for cardiovascular disease drug Ticagrelor in two strengths
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.